Evidence map›Paper›PMID 40447228›Full record

Trial reportBiological psychiatry. Cognitive neuroscience and neuroimaging2025

Computationally Informed Insights Into Anhedonia and Treatment by Kappa Opioid Receptor Antagonism.

Bilal A Bari, Andrew D Krystal, Diego A Pizzagalli, Samuel J Gershman

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bilal A BariDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; McLean Hospital, Harvard Medical School, Belmont, Massachusetts. Electronic address: bbari@mgh.harvard.edu.
Andrew D KrystalDepartment of Psychiatry, University of California San Francisco, San Francisco, California; Departments of Psychiatry and Behavioral Sciences and Radiology, Duke University School of Medicine, Durham, North Carolina.
Diego A PizzagalliMcLean Hospital, Harvard Medical School, Belmont, Massachusetts.
Samuel J GershmanDepartment of Psychology and Center for Brain Science, Harvard University, Cambridge, Massachusetts; Center for Brains, Minds, and Machines, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Funding

Project 4_Bruchas : Circuit-level Approaches for Dissecting Approach/Avoidance Behaviors Mediated by Nociceptin Systems in MiceP50MH119467 · NIMH · MCLEAN HOSPITAL · PI FRANK, MICHAEL J. · 2020 to 2024
$15.9M
Neuroimaging Studies of Reward Processing in DepressionR37MH068376 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI Diego A Pizzagalli · 2016 to 2026
$7.4M
Fostering Research Mentorship & Training during Psychiatry Residency SupplementR25MH094612 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI FAVA, MAURIZIO, GREENFIELD, SHELLY F. · 2011 to 2022
$2.3M
Multi level Analysis of Positive Valence Systems Across Mood DisordersR01MH101521 · NIMH · MCLEAN HOSPITAL · PI PIZZAGALLI, DIEGO A · 2013 to 2016
$2.1M
NIMH NIH HHS P50 MH119467NIMH NIH HHS R01 MH101521NIMH NIH HHS R25 MH094612NIMH NIH HHS R37 MH068376Wellcome Trust
6 · The paper itself

Abstract

backgroundAnhedonia, the loss of pleasure, is prevalent and impairing. Parsing its computational basis promises to explain its transdiagnostic character. One manifestation of anhedonia, reward insensitivity, may be linked to limited memory. Furthermore, the need to economize on limited memory engenders a perseverative bias toward frequently chosen actions. Anhedonia may also be linked with deviations from optimal perseveration for a given memory capacity, a pattern that causes inefficiency because it results in less reward for the same memory cost.

methodsTo test these hypotheses, we applied a theory of optimal decision making under memory constraints that decomposes behavior into a memory component and an efficiency component. We applied this theory to behavior on the Probabilistic Reward Task, a reward learning paradigm that has been validated in anhedonia, and performed secondary analysis of a randomized controlled trial testing kappa opioid receptor (KOR) antagonism for anhedonia (n = 24 KOR; n = 31 placebo), as well as analyses of 3 other datasets (n = 100, 66, 24, respectively). We fit a resource-bounded reinforcement learning model to behavior.

resultsAcross clinical and nonclinical populations, anhedonia was associated with deficits in efficiency but not memory. The reinforcement learning models demonstrated that deficits in efficiency arise from the inability to perseverate optimally. KOR antagonism, which likely elevates tonic dopamine, increases both memory and efficiency, and the model demonstrated that this arises from increased reward sensitivity and perseveration.

conclusionsTherefore, KOR antagonism has distinct cognitive effects, only one related to anhedonia. These findings have potential implications for the applications of KOR antagonists.

Indexed as

AnhedoniaNarcotic AntagonistsReceptors, Opioid, kappaAdultDecision MakingFemaleHumansMaleMemoryMiddle AgedReinforcement, PsychologyRewardYoung AdultNarcotic AntagonistsReceptors, Opioid, kappaAnhedoniaComputational psychiatryLearning and memoryPsychopharmacologyReinforcement learningResource rationality

Identifiers

PMID40447228
PMCPMC12354190

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.